ClinConnect ClinConnect Logo
Search / Trial NCT06774924

"Clinical Ultrasound, a New Link Between Town and Hospital in Seine-Saint-Denis". (ECHO93)

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jan 13, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

The ECHO93 study is looking at how a special device called the echOpen probe can help doctors diagnose patients more quickly. This study will be conducted in different locations, starting with the Rapid Diagnosis Unit at Jean Verdier Hospital, and then expanding to other medical practices and a mobile health bus. The goal is to see if using this device makes a difference in the time it takes for patients to get their diagnoses.

To participate in this study, you need to be an adult over 18 years old and able to give your consent. You should also be referred to one of the participating locations for a quick diagnosis. However, there are a few reasons why someone might not be able to join, like having certain health conditions or not being able to communicate in French without help. If you decide to take part, you can expect to be involved in a process aimed at improving how quickly and effectively patients receive their diagnosis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adult patient over 18 years of age
  • 2. Patient with signed informed consent
  • 3. Patient managed by:
  • one of the structures involved (UDR/ SAU Jean Verdier, MSP Pantin, Cabinet Médical du Dr TAYBALY à Aulnay-sous-Bois) for referral to the UDR for rapid diagnosis (phases 1 and 2)
  • the Health Bus (phase 3)
  • Exclusion Criteria:
  • 1. Patient on the UDR iron-deficiency anemia clinical pathway
  • 2. Patient deprived of liberty by judicial or administrative decision
  • 3. Patient who does not speak French and cannot benefit from the presence of a relative or translator (physical or online)
  • 4. Patient with a contraindication to the use of EchOPen:
  • patients with a body mass index greater than 34.9 kg/m2
  • life-threatening patients requiring emergency medical care.

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Patients applied

0 patients applied

Trial Officials

Anne BOURGARIT, PUPH

Study Director

HUPSSD

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported